Literature DB >> 22285152

Glutamine in the pathogenesis of acute hepatic encephalopathy.

Kakulavarapu V Rama Rao1, Arumugam R Jayakumar, Michael D Norenberg.   

Abstract

Hepatic encephalopathy (HE) is the major neurological disorder associated with liver disease. It presents in chronic and acute forms, and astrocytes are the major neural cells involved. While the principal etiological factor in the pathogenesis of HE is increased levels of blood and brain ammonia, glutamine, a byproduct of ammonia metabolism, has also been implicated in its pathogenesis. This article reviews the current status of glutamine in the pathogenesis of HE, particularly its involvement in some of the events triggered by ammonia, including mitochondrial dysfunction, generation of oxidative stress, and alterations in signaling mechanisms, including activation of mitogen-activated protein kinases (MAPKs) and nuclear factor-kappaB (NF-κB). Mechanisms by which glutamine contributes to astrocyte swelling/brain edema associated with acute liver failure (ALF) will also be described. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22285152     DOI: 10.1016/j.neuint.2012.01.012

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  15 in total

Review 1.  Glutamine in the pathogenesis of hepatic encephalopathy: the trojan horse hypothesis revisited.

Authors:  Kakulavarapu V Rama Rao; Michael D Norenberg
Journal:  Neurochem Res       Date:  2013-01-01       Impact factor: 3.996

2.  Enzymatic analysis of α-ketoglutaramate--a biomarker for hyperammonemia.

Authors:  Lenka Halámková; Shay Mailloux; Jan Halámek; Arthur J L Cooper; Evgeny Katz
Journal:  Talanta       Date:  2012-08-24       Impact factor: 6.057

Review 3.  Acetyl-L-carnitine in hepatic encephalopathy.

Authors:  Michele Malaguarnera
Journal:  Metab Brain Dis       Date:  2013-02-08       Impact factor: 3.584

Review 4.  In vivo studies of brain metabolism in animal models of Hepatic Encephalopathy using ¹H Magnetic Resonance Spectroscopy.

Authors:  Cristina Cudalbu
Journal:  Metab Brain Dis       Date:  2012-12-21       Impact factor: 3.584

Review 5.  Update on cerebral uptake of blood ammonia.

Authors:  Michael Sørensen
Journal:  Metab Brain Dis       Date:  2013-03-13       Impact factor: 3.584

Review 6.  Ammonia toxicity to the brain.

Authors:  Olivier Braissant; Valérie A McLin; Cristina Cudalbu
Journal:  J Inherit Metab Dis       Date:  2012-10-30       Impact factor: 4.982

7.  Effect of glutamine synthetase inhibition on brain and interorgan ammonia metabolism in bile duct ligated rats.

Authors:  Andreas W Fries; Sherry Dadsetan; Susanne Keiding; Lasse K Bak; Arne Schousboe; Helle S Waagepetersen; Mette Simonsen; Peter Ott; Hendrik Vilstrup; Michael Sørensen
Journal:  J Cereb Blood Flow Metab       Date:  2013-12-18       Impact factor: 6.200

Review 8.  Pathogenesis of brain edema and investigation into anti-edema drugs.

Authors:  Shotaro Michinaga; Yutaka Koyama
Journal:  Int J Mol Sci       Date:  2015-04-30       Impact factor: 5.923

9.  Dysbalance of astrocyte calcium under hyperammonemic conditions.

Authors:  Nicole Haack; Pavel Dublin; Christine R Rose
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

10.  Plasma glutamine status at intensive care unit admission: an independent risk factor for mortality in critical illness.

Authors:  Marie Smedberg; Johan Helleberg; Åke Norberg; Inga Tjäder; Olav Rooyackers; Jan Wernerman
Journal:  Crit Care       Date:  2021-07-07       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.